Skip to main content
. 2021 Jan 8;13(1):174. doi: 10.3390/nu13010174

Table 4.

Assessment of gastrointestinal symptoms.

Placebo (n = 12) Xylitol 7 g (n = 12) Xylitol 17 g (n = 12) Xylitol 35 g (n = 12)
Abdominal pain No of subjects with symptom 0 0 0 0
max severity * - - - -
Nausea No of subjects with symptom 0 0 0 0
max severity - - - -
Vomiting No of subjects with symptom 0 0 0 0
max severity - - - -
Diarrhea No of subjects with symptom 0 0 0 0
max severity - - - -
Bowel sounds No of subjects with symptom 5 9 8 9
max severity 1.4 1.0 1.25 1.0
Bloating No of subjects with symptom 0 0 1 1
max severity - - 1.0 1.0
Eructation No of subjects with symptom 0 1 0 0
max severity - 1.0 - -
Flatulence No of subjects with symptom 0 0 0 0
max severity - - - -

* severity score 1 = mild; 2 = severe. Gastrointestinal symptoms were assessed by the use of a checklist. Participants were asked to choose between “no symptom” (0 points), “mild symptoms“ (1 point) and “severe symptoms” (2 points) for each item.